Baseline characteristics were descriptively similar for semaglutide 2.4 mg and tirzepatide: mean age was 47.8 and 49.5 years, 79.8% and 77.9% were female, and mean index weight was 104.5 and 104.9 kg, respectively
What should a reader compare next
For example, GLP-1 medications such as Wegovy, Saxenda and Zepbound generally require a two-week observation period after starting treatment and a 72-hour observation period after each dosage increase
However, the benefits of the metabolic shifts induced by GLP-1 use may outweigh the risks of hair loss, especially since hair loss is considered a temporary side effect
Yes, in most cases but it requires closer INR monitoring than usual, particularly during the first few months
Nothing got funky or smelled strange even after sitting outside for a few hours